Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience
- PMID: 27247011
- DOI: 10.1093/europace/euw026
Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience
Abstract
Aims: The purpose of this study was to analyse the efficacy and complication rates of the simultaneous hybrid procedure in a series of patients with persistent and long-standing persistent atrial fibrillation (AF) in a midterm follow-up.
Methods and results: Sixty-four consecutive patients (56 males, 59.7 ± 8.7 years) having undergone isolation of pulmonary veins (PVs) and posterior wall of left atrium (LA) by means of hybrid thoracoscopic ablation for symptomatic persistent (n = 21, 33%) and long-standing persistent AF (n = 43, 67%) were analysed. At a mean follow-up of 23.1 ± 14.1 months (median 21; range 6-57), the success rate without antiarrhythmic therapy was achieved in 67.2% of patients. Procedure-related complications were observed in 13 patients (20.3%) including 2 LA perforations (3.1%) requiring, respectively, conversion to sternotomy and small left-sided thoracotomy. The success rate did not significantly differ between persistent and long-standing persistent AF (respectively, 71.4 and 65.1%; P = 0.4). Patients with AF relapse during the blanking period were 4.60 times more likely to have AF recurrence after 3 months from the ablation procedure.
Conclusion: The hybrid procedure yields promising results in the setting of both persistent and long-standing persistent AF after midterm follow-up, at the expense of a non-negligible rate of adverse events. Our findings need to be confirmed by further larger and prospective studies.
Keywords: Catheter ablation; Hybrid procedure; Long-standing persistent atrial fibrillation; Pulmonary vein isolation; Surgical ablation.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For permissions please email: journals.permissions@oup.com.
Comment in
-
The future of hybrid ablation: an emerging need for an anticoagulation protocol for thoracoscopic ablation.J Thorac Dis. 2017 Mar;9(3):E322-E326. doi: 10.21037/jtd.2017.02.95. J Thorac Dis. 2017. PMID: 28449532 Free PMC article.
-
Surgical perspective on hybrid ablation for non-paroxysmal atrial fibrillation.J Thorac Dis. 2017 Dec;9(12):4937-4940. doi: 10.21037/jtd.2017.11.146. J Thorac Dis. 2017. PMID: 29312696 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical